Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.

NCT00974259 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00974259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00974259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2014
Enrollment
122 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

severe traumatic brain injury